These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 33158717)

  • 1. Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study.
    Xia L; Shi Y; Su J; Friedemann T; Tao Z; Lu Y; Ling Y; Lv Y; Zhao R; Geng Z; Cui X; Lu H; Schröder S
    Phytomedicine; 2021 May; 85():153390. PubMed ID: 33158717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential therapeutic effect of Shufeng Jiedu capsule and its major herbs on coronavirus disease 2019 (COVID-19): A review.
    Xu Y; Yang L; Wang L; Chen F
    Drug Discov Ther; 2022 Jan; 15(6):289-299. PubMed ID: 34980761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI.
    Cai J; Wang YL; Sheng XD; Zhang L; Lv X
    J Ethnopharmacol; 2022 Nov; 298():115661. PubMed ID: 36002086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.
    Wang Z; Chen X; Lu Y; Chen F; Zhang W
    Biosci Trends; 2020 Mar; 14(1):64-68. PubMed ID: 32037389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation.
    Zhuang Z; Zhong X; Zhang H; Chen H; Huang B; Lin D; Wen J
    Comb Chem High Throughput Screen; 2021; 24(9):1377-1394. PubMed ID: 33135607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shufeng Jiedu capsule ameliorates olfactory dysfunction via the AMPK/mTOR autophagy pathway in a mouse model of allergic rhinitis.
    Chen H; Cheng Y; Du H; Zhang C; Zhou Y; Zhao Z; Li Y; Friedemann T; Mei J; Schröder S; Chen M
    Phytomedicine; 2022 Dec; 107():154426. PubMed ID: 36116201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology.
    Chen X; Yin YH; Zhang MY; Liu JY; Li R; Qu YQ
    Int J Med Sci; 2020; 17(16):2511-2530. PubMed ID: 33029094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
    Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
    Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease.
    Ji S; Bai Q; Wu X; Zhang DW; Wang S; Shen JL; Fei GH
    Biomed Pharmacother; 2020 Jan; 121():109652. PubMed ID: 31734578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking.
    Simayi J; Nuermaimaiti M; Wumaier A; Khan N; Yusufu M; Nuer M; Maihemuti N; Bayinsang ; Adurusul K; Zhou W
    Medicine (Baltimore); 2022 Jan; 101(1):e28286. PubMed ID: 35029877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cangma Huadu granules, a new drug with great potential to treat coronavirus and influenza infections, exert its efficacy through anti-inflammatory and immune regulation.
    Cui XR; Guo YH; Liu QQ
    J Ethnopharmacol; 2022 Apr; 287():114965. PubMed ID: 34990767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study.
    Chen J; Lin S; Niu C; Xiao Q
    Expert Rev Respir Med; 2021 Feb; 15(2):257-265. PubMed ID: 32941741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shufeng Jiedu capsule alleviates influenza A (H1N1) virus induced acute lung injury by regulating the lung inflammatory microenvironment.
    Wang X; Geng Z; Bao Y; Zhong J; Ma J; Cui X; Shi Y
    Heliyon; 2024 Jun; 10(12):e33237. PubMed ID: 39021925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia.
    Tao Z; Zhang L; Friedemann T; Yang G; Li J; Wen Y; Wang J; Shen A
    J Funct Foods; 2020 Dec; 75():104243. PubMed ID: 33072190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems pharmacology approach to explore the mechanisms of shufeng Jiedu Capsule on treating H1N1 infection.
    Mei Z; Zhang J; Chen X; He Y; Feng J; Du Y; Shi J; Jie Z
    Drug Dev Ind Pharm; 2023 Jun; 49(6):405-415. PubMed ID: 37279006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.
    Xia J; Rong L; Sawakami T; Inagaki Y; Song P; Hasegawa K; Sakamoto Y; Tang W
    Biomed Pharmacother; 2018 Mar; 99():921-930. PubMed ID: 29710492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating patients infected with the SARS-CoV-2 Omicron variant with a traditional Chinese medicine, Shufeng Jiedu capsule.
    Zhang J; Liu L; Zhang G; Li M; Ma B; Yang W
    Biosci Trends; 2022 Jul; 16(3):238-241. PubMed ID: 35732417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shufeng Jiedu capsules protect rats against LPS-induced acute lung injury via activating NRF2-associated antioxidant pathway.
    Liao Q; Chen W; Tong Z; Xue M; Gu T; Yuan Y; Song Z; Tao Z
    Histol Histopathol; 2021 Mar; 36(3):317-324. PubMed ID: 33346364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
    Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
    J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.